Andon Health Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000Q84
CNY
68.05
-0.94 (-1.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Andon Health Co., Ltd.

Why is Andon Health Co., Ltd. ?

1
The company has declared Negative results for the last 13 consecutive quarters
  • INTEREST(Q) At CNY 29.75 MM has Grown at 15.02%
  • NET PROFIT(Q) At CNY 56.7 MM has Fallen at -46.47%
  • DEBT-EQUITY RATIO (HY) Highest at -8.67 %
2
With ROE of 1.24%, it has a very attractive valuation with a 1.43 Price to Book Value
  • Over the past year, while the stock has generated a return of 93.14%, its profits have fallen by -72.9%
  • At the current price, the company has a high dividend yield of 2.7
3
Market Beating performance in long term as well as near term
  • Along with generating 93.14% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Andon Health Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Andon Health Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Andon Health Co., Ltd.
88.66%
1.21
54.30%
China Shanghai Composite
20.18%
1.55
13.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-10.58%
EBIT Growth (5y)
-210.52%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.31
Sales to Capital Employed (avg)
0.09
Tax Ratio
14.26%
Dividend Payout Ratio
31.55%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
109.99%
ROE (avg)
25.58%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
116
Industry P/E
Price to Book Value
1.43
EV to EBIT
-80.33
EV to EBITDA
-96.62
EV to Capital Employed
1.48
EV to Sales
25.08
PEG Ratio
NA
Dividend Yield
2.72%
ROCE (Latest)
-1.84%
ROE (Latest)
1.24%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 1,494.84 MM

ROCE(HY)

Highest at 10.66%

RAW MATERIAL COST(Y)

Fallen by -1.1% (YoY

-31What is not working for the Company
INTEREST(Q)

At CNY 29.75 MM has Grown at 15.02%

NET PROFIT(Q)

At CNY 56.7 MM has Fallen at -46.47%

DEBT-EQUITY RATIO (HY)

Highest at -8.67 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.61 times

NET SALES(Q)

At CNY 301.48 MM has Fallen at -11.69%

Here's what is working for Andon Health Co., Ltd.

Operating Cash Flow
Highest at CNY 1,494.84 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Raw Material Cost
Fallen by -1.1% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Andon Health Co., Ltd.

Interest
At CNY 29.75 MM has Grown at 15.02%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Profit
At CNY 56.7 MM has Fallen at -46.47%
over average net sales of the previous four periods of CNY 105.93 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales
At CNY 301.48 MM has Fallen at -11.69%
over average net sales of the previous four periods of CNY 341.4 MM
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Debt-Equity Ratio
Highest at -8.67 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio
Lowest at 2.61 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio